Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155775 · ClinicalTrials.gov registry record · NA
Effects of a Platelet Transfusion Best Practices Alert
A NA study of Thrombocytopenia, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 446
- Enrollment target
- 1
- Study location
NCT04155775 is a NA study of Thrombocytopenia that has completed, run by Stanford University. The registered enrollment target is 446 participants, above the 290-participant average among 20 other Thrombocytopenia trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04155775, a NA study of Thrombocytopenia, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 446 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to determine the effectiveness of a computerized clinical decision support tool (Best Practice Alert - BPA) in reducing unnecessary platelet transfusions based on guidelines published by national transfusion societies such as the AABB (formerly American Association of Blood Banks).
Conditions Studied
Interventions
- OTHER Computer electronic health record alert (Best Practice Alert - BPA)
Study Locations (1)
California
- Stanford Healthcare - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2019-05-09 |
| Est. Completion | 2020-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04155775
The ClinicalTrials.gov registry entry for NCT04155775 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 446 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 290-participant average among 20 other Thrombocytopenia trials with a reported enrollment target (54% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thrombocytopenia appearing as the primary indexed condition, and to 1 intervention - of which Computer electronic health record alert (Best Practice Alert - BPA) is the first listed.
NCT04155775 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04155775 about?
NCT04155775 is a clinical study titled "Effects of a Platelet Transfusion Best Practices Alert". This study is to determine the effectiveness of a computerized clinical decision support tool (Best Practice Alert - BPA) in reducing unnecessary platelet transfusions based on guidelines published by national transfusion societies such as the AABB (formerly American Association of Blood Banks).
What is the current status of trial NCT04155775?
This trial is currently completed. It is a NA study. The enrollment target is 446 participants. The study started on 2019-05-09. Estimated completion is 2020-02-04.
What conditions does trial NCT04155775 study?
This clinical trial studies the following conditions: Thrombocytopenia.
What interventions are being tested in trial NCT04155775?
The interventions under investigation include: Computer electronic health record alert (Best Practice Alert - BPA) (OTHER).
Who is sponsoring clinical trial NCT04155775?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04155775 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombocytopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Platelet-Directed Whole Blood Transfusion Strategy for Malaria
RECRUITING · NA
-
Neonatal Platelet Transfusion Threshold Trial
RECRUITING · NA
-
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
RECRUITING · NA
-
Stem Cell Transplantation (SCT) for Genetic Diseases
COMPLETED · NA
-
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
COMPLETED · NA
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.